Challenges and controversies in fetal diagnosis and treatment: hypoplastic left heart syndrome

Michele A Frommelt1

  • 1Division of Cardiology, Children's Hospital of Wisconsin, 9000 West Wisconsin Avenue, Milwaukee, WI 53201, USA.

Clinics in Perinatology
|December 3, 2014
PubMed

Insights

Survival for hypoplastic left heart syndrome (HLHS) has improved, but challenges remain. Advances in prenatal diagnosis and fetal intervention offer new hope for affected infants.

Area of Science:

  • Pediatric Cardiology
  • Fetal Medicine
  • Congenital Heart Disease

Background:

  • Hypoplastic Left Heart Syndrome (HLHS) affects infant heart development.
  • Current survival rates for HLHS into adulthood approach 70%.
  • Significant long-term morbidity and mortality persist despite advances.

Purpose of the Study:

  • To highlight the increasing prevalence and benefits of prenatal HLHS diagnosis.
  • To discuss emerging fetal interventions for HLHS.
  • To inform pediatric cardiologists about advancements in HLHS management.

Main Methods:

  • Review of current literature on HLHS diagnosis and treatment.
  • Analysis of progress in fetal diagnostic techniques.
  • Examination of outcomes for fetal interventional cardiology.

Main Results:

  • Prenatal diagnosis of HLHS is becoming more common.
  • Fetal interventions, such as catheter procedures, show promise.
  • Improved counseling and potential for early intervention are key benefits.

Conclusions:

  • Pediatric cardiologists must be aware of HLHS treatment limitations.
  • Emerging fetal diagnostic and interventional strategies are crucial.
  • Continued research in fetal medicine is vital for improving HLHS outcomes.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
5.1K
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
1.3K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
724